The impact of morning symptoms on daily activities in chronic obstructive pulmonary disease.

Abstract:

BACKGROUND:This survey assessed the impact of symptoms of COPD on patients' ability to perform activities throughout the day and the extent to which physicians provided advice including how medications may help maintain quality of life. METHODS:The survey had three inclusion criteria--physician's diagnosis of COPD, age 30-70 years and presence of at least one of four listed symptoms to a greater extent in the morning. Participants were randomly selected from a panel who had previously agreed to participate in surveys. The survey was conducted in eight countries and contained 31 questions in the main section on the effects of symptoms of COPD throughout the day on patients' ability to perform tasks, how patients adjusted their lives and the extent to which physicians offered advice and support. RESULTS:Routine activities took 10-15 minutes longer and more strenuous activities around 30 minutes longer than before symptoms had become worse in the morning. Half had made changes to their morning routines and just over half confirmed that morning symptoms affected the rest of their day. The majority believed their medications provided sufficient relief of morning symptoms but less than a quarter believed they helped improve their ability to perform tasks. Physicians were unlikely to discuss this aspect of patient care routinely even though there was evidence to suggest that the challenge of performing tasks had a greater impact on patients than the symptoms themselves. CONCLUSIONS:Morning symptoms of COPD can severely compromise patients' ability to perform tasks throughout the day. Despite this, physicians are unlikely to discuss with patients how their ability to perform tasks might be improved.

journal_name

Curr Med Res Opin

authors

O'Hagan P,Chavannes NH

doi

10.1185/03007995.2013.857648

subject

Has Abstract

pub_date

2014-02-01 00:00:00

pages

301-14

issue

2

eissn

0300-7995

issn

1473-4877

journal_volume

30

pub_type

杂志文章
  • Economic burden and co-morbidities of atrial fibrillation in a privately insured population.

    abstract:OBJECTIVE:This study assesses the direct (medical and drugs) and indirect (work loss) annual costs associated with Atrial Fibrillation (AFIB) in a privately insured population. BACKGROUND:AFIB is the most common sustained rhythm disturbance, affecting 2.3 million people in the United States. METHODS:Cost and co-morbi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079905X65475

    authors: Wu EQ,Birnbaum HG,Mareva M,Tuttle E,Castor AR,Jackman W,Ruskin J

    更新日期:2005-10-01 00:00:00

  • Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.

    abstract:OBJECTIVE:Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) and fingolimod are approved oral disease-modifying treatments for relapsing-remitting multiple sclerosis. In phase 3 trials, DMF (DEFINE/CONFIRM) and fingolimod (FREEDOMS/FREEDOMS II) resulted in significant reductions in clinical and...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1080/03007995.2016.1248380

    authors: Fox RJ,Chan A,Zhang A,Xiao J,Levison D,Lewin JB,Edwards MR,Marantz JL

    更新日期:2017-02-01 00:00:00

  • Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children.

    abstract:OBJECTIVE:These studies evaluated the safety and efficacy of enteric-coated budesonide for the induction and maintenance of remission of mild-to-moderate Crohn's disease (CD) in children. METHODS:The consecutive, multicenter, open-label, non-comparative studies enrolled patients aged 6-17 years. In the induction study...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1080/03007995.2017.1313213

    authors: Cohen SA,Aloi M,Arumugam R,Baker R,Bax K,Kierkuś J,Koletzko S,Lionetti P,Persson T,Eklund S

    更新日期:2017-07-01 00:00:00

  • A controlled study of benzydamine oral rinse ("Difflam") in general practice.

    abstract::Fifty-two patients suffering from presumed viral pharyngeal infection or tonsillitis were treated with either benzydamine or placebo oral rinse as a gargle at 3-hourly intervals in a randomized double-blind study. Patients on the active preparation experienced faster resolution of pain and dysphagia and at 7 days 88% ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998209112381

    authors: Whiteside MW

    更新日期:1982-01-01 00:00:00

  • Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.

    abstract:OBJECTIVE:Patients receiving levodopa for Parkinson's disease experience motor fluctuations and immobility ('off' episodes) between doses. This study assessed adjunctive Zelapar (selegiline orally disintegrating tablet (ODT)) for managing off episodes and for long-term safety. METHODS:This open-label extension evaluat...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079906x167697

    authors: Lew MF,Pahwa R,Leehey M,Bertoni J,Kricorian G,Zydis Selegiline Study Group.

    更新日期:2007-04-01 00:00:00

  • Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions.

    abstract::The results of recent clinical trials with rivastigmine show that in the approved indication of mild to moderate Alzheimer's disease (AD), the drug is effective in the long term. Rivastigmine produces a significant delay in the decline of the three components of AD that have been identified by European guidelines as e...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/0300799039117029

    authors: Gabelli C

    更新日期:2003-01-01 00:00:00

  • The clinical diagnosis of influenza.

    abstract::Effective management of influenza depends on early recognition of influenza in the community and on rapid diagnosis. Early recognition is achieved by integrated clinical and laboratory based surveillance programmes in representative populations. The recent introduction of 'near patient tests' for influenza provide inc...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079902125000921

    authors: Fleming D,Wood M

    更新日期:2002-01-01 00:00:00

  • Availability of post-trial access in clinical trials: a review of clinical trial protocols submitted to the research ethics board of the University of the Philippines Manila.

    abstract::Objectives: Ethics guidelines such as the Declaration of Helsinki and the CIOMS International Ethical Guidelines for Health-related Research Involving Humans require the sponsors, in cooperation with relevant stakeholders, to provide post-trial access (PTA) to intervention and knowledge, especially in clinical trials ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2019.1644851

    authors: Jimenez EB,Virtudazo JMP,Torres CE,Bernabe RD

    更新日期:2019-11-01 00:00:00

  • The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.

    abstract:OBJECTIVE:In addition to direct weight reduction, there may be other benefits of obesity treatment including improved insulin sensitivity. The purpose of this study was to characterise concomitant diabetes drug use and the related costs in patients with diabetes treated with orlistat (Xenical) in the first 6 months of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079905X74943

    authors: Rowe R,Cowx M,Poole C,McEwan P,Morgan C,Walker M

    更新日期:2005-11-01 00:00:00

  • Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects.

    abstract::In a double-blind study of 102 patients with a mean age of 79 years, zopiclone was compared to flunitrazepam. The patients rated their sleep in a diary. There was no statistically significant difference between the relatively low dose of 5 mg zopiclone and 1 mg flunitrazepam for eleven out of the twelve variables meas...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007999509110492

    authors: Dehlin O,Rubin B,Rundgren A

    更新日期:1995-01-01 00:00:00

  • Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome?

    abstract:OBJECTIVE:To investigate the effect of fenofibrate on sleep apnoea indices. METHODS:Proof-of-concept study comprising a placebo run-in period (1 week, 5 weeks if fibrate washout was required) and a 4-week randomized, double-blind treatment period. Thirty-four subjects (mean age 55 years, body mass index 34 kg/m 2 , fa...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007991003693581

    authors: Bruckert E,Duchêne E,Bonnefont-Rousselot D,Hansel B,Ansquer JC,Dubois A,Gaymard B

    更新日期:2010-05-01 00:00:00

  • A comparison of cefamandole, cefoxitin, cefuroxime, cefotaxime and cefoperazone: an in vitro test on a number of beta-lactamase producing strains of 9 species and 1 genus of bacteria.

    abstract::The sensitivity of a number of beta-lactamase producing strains of Enterobacter aerogenes, Enterobacter cloacae, Enterobacter species, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa and Serratia marcescens to cefamandole, cefoxitin, cefuroxi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998109114263

    authors: Kuipers JS

    更新日期:1981-01-01 00:00:00

  • A comparison of faecal blood loss caused by tenoxicam and piroxicam in normal healthy male volunteers.

    abstract::Faecal blood loss arising from tenoxicam at a dose of 20 mg/day was compared to that arising from piroxicam at a dose of 20 mg/day in a double-blind, parallel comparative study in 12 healthy male volunteers. Faecal blood loss was measured for a 1-week run-in on placebo, during 4 weeks of treatment and for a 2-week pos...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998509109629

    authors: Bird HA,Hill J,Haw WM,Dixon JS,Harris PA,Wright V

    更新日期:1985-01-01 00:00:00

  • Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux.

    abstract:OBJECTIVE:Vesicoureteral reflux (VUR) occurs in approximately 1% of infants and children and is associated with recurrent urinary tract infections (UTIs). The objective of this paper is to examine the use of endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA) as a curative option and as an alternati...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079907X226230

    authors: Elder JS,Shah MB,Batiste LR,Eaddy M

    更新日期:2007-09-01 00:00:00

  • Changing trends in osteoporosis care from specialty to primary care physicians.

    abstract:BACKGROUND:Inadequate treatment by non-specialty primary care physicians (PCPs) has been a concern in improving osteoporosis care. An increase in outpatient visits by older patients seeking osteoporosis care has been reported. But what percentages of these visits are made to PCPs are unknown. We investigated recent tre...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.809335

    authors: Rianon N,Anand D,Rasu R

    更新日期:2013-08-01 00:00:00

  • Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.

    abstract::A double-blind, crossover trial was carried out in 40 in-patients with gastro-intestinal spasmodic syndromes to compare the effectiveness and tolerance of fenoverine and trimebutine. Patients were allocated at random to receive either 100 mg fenoverine or 150 mg trimebutine 3-times daily for 20 days and were then cros...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998609111090

    authors: Camarri E

    更新日期:1986-01-01 00:00:00

  • Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy.

    abstract:BACKGROUND AND OBJECTIVES:Reduction in total cholesterol (TC) and LDL-cholesterol (LDL-C) forms one of the principal objectives of most cardiovascular secondary prevention strategies. Many patients being treated with statins, however, have significant residual dyslipidaemia, with many having suboptimal HDL-cholesterol ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990802374633

    authors: Belsey J,de Lusignan S,van Vlymen J,Chan T,Hague N

    更新日期:2008-09-01 00:00:00

  • Observational study of adjuvant therapy with capecitabine in colon cancer.

    abstract:OBJECTIVE:This observational study was conducted to document the safety of capecitabine-based adjuvant therapy in patients with resected colon cancer under routine clinical conditions. RESEARCH AND DESIGN METHODS:ML20431 was a prospective, multicenter, non-interventional, observational study. It was designed to answer...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007995.2015.1014030

    authors: Steffens CC,Tschechne B,Schardt C,Jacobs G,Valdix AR,Schmidt P,Hansen R,Kröning H,Wohlfarth T,Guggenberger D

    更新日期:2015-04-01 00:00:00

  • Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy.

    abstract:BACKGROUND:The selection of the most appropriate treatment combinations requires the balancing of benefits and harms of these treatment options as well as the patients' preferences for the resulting outcomes. OBJECTIVE:This research aimed at estimating and comparing the utility weights between elderly women with early...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1257983

    authors: Ali AA,Xiao H,Tawk R,Campbell E,Semykina A,Montero AJ,Diaby V

    更新日期:2017-02-01 00:00:00

  • Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease.

    abstract::Studies in several populations have indicated that genetic variation at the apolipoprotein E (apoE) structural locus influences the risk of coronary artery disease (CAD) and myocardial infarction (MI). This study aimed at investigating whether apoE polymorphism has an allelic and/or genotypic impact on the risk of MI ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079902125000444

    authors: Kolovou G,Yiannakouris N,Hatzivassiliou M,Malakos J,Daskalova D,Hatzigeorgiou G,Cariolou MA,Cokkinos DV

    更新日期:2002-01-01 00:00:00

  • Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

    abstract:OBJECTIVES:Docetaxel and paclitaxel show significant clinical activity in metastatic breast cancer (MBC) and have been approved for MBC by the U.S. Food and Drug Administration, but it is still unclear whether a paclitaxel-based regimen improves outcomes over a docetaxel-based regimen in patients with MBC. We therefore...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析,评审

    doi:10.1185/03007995.2012.756393

    authors: Qi WX,Shen Z,Lin F,Sun YJ,Min DL,Tang LN,He AN,Yao Y

    更新日期:2013-02-01 00:00:00

  • A comparative trial of 400 mg cimetidine twice daily and 1000 mg daily in the short-term treatment of duodenal ulceration.

    abstract::The therapeutic efficacy of cimetidine given as 400 mg twice daily was compared to that of cimetidine given as 1.0 g daily in 4 divided doses (200 mg 3-times daily and 400 mg at night) in two groups of 25 patients (total 50 patients) with active duodenal ulceration. After 4 weeks, healing rates of 72% and 76%, respect...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998509109626

    authors: Papadopoulos C,Kalantzis N,Rekoumis G,Kanaghinis T

    更新日期:1985-01-01 00:00:00

  • The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on losartan.

    abstract::Optimal management of hypertension has been shown to reduce the risk of stroke. In recent years, newer classes of antihypertensive such as the angiotensin II (Ang II) antagonists have become available. Results from the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study suggest the utility of thi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079904X10160

    authors: Ferrario CM

    更新日期:2004-11-01 00:00:00

  • Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage.

    abstract::Drs Godman and Fadare review the paper by Mares-Garcia and colleagues in Spain regarding the extent of non-guideline recommended prescribing (NGRP) of proton pump inhibitors (PPIs) in ambulatory care. NGRP of PPIs is an increasing public health concern given the implications of overuse of PPIs on infection rates, oste...

    journal_title:Current medical research and opinion

    pub_type: 评论,杂志文章

    doi:10.1080/03007995.2017.1358159

    authors: Godman B,Fadare J

    更新日期:2017-11-01 00:00:00

  • The SCORE model in the POWER study: an attempt to focus the limited resources for prevention on patients with greatest need.

    abstract::As the emergence of cardiovascular disease (CVD) is linked to modifiable lifestyle and physiological factors, it is increasingly important to concentrate on preventative strategies. For preventative measures to be beneficial it is necessary to clearly identify patients at risk--given that multiple risk factors often c...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079907X260728

    authors: De Backer G

    更新日期:2007-11-01 00:00:00

  • Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.

    abstract::Objective: The aim of this study was to investigate the impact of methodological choices in a meta-analysis of real-world evidence (RWE) comparing three non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists (VKAs) for the treatment of patients with non-valvular atrial fibrillation (NVAF). Methods: Th...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1080/03007995.2019.1647020

    authors: Briere JB,Wu O,Bowrin K,Millier A,Toumi M,Taieb V,Levy P,Coleman CI

    更新日期:2019-11-01 00:00:00

  • Ways to increase adherence to allergen immunotherapy.

    abstract::Adherence to allergen immunotherapy (AIT) is crucial for its efficacy. Subcutaneous AIT requires monthly visits (or more extended in the case of venom immunotherapy), while sublingual AIT is performed with a daily intake of allergen drops. Non-adherence to an AIT schedule and premature discontinuation are common probl...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2018.1552044

    authors: Pitsios C,Dietis N

    更新日期:2019-06-01 00:00:00

  • Clinical investigation of a very low dosage oral contraceptive combination: 0-75 mg lynestrenol and 0-0375 mg ethinyl oestradiol.

    abstract::A trial was carried out in 3 clinics to test the efficacy of and cycle control obtained with a very low dosage oral contraceptive combination of lynesternol (0.75 mg) and ethinyl oestradiol (0.0375 mg). A total of 134 healthy, fertile women, ages ranging from under 19 years to over 40 years, participated and completed...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007997609109328

    authors: Altkemper R,Prinz W,Soergel W

    更新日期:1976-01-01 00:00:00

  • The prevalence of anemia in patients with chronic kidney disease.

    abstract:OBJECTIVE:Anemia is a complication of chronic kidney disease and may contribute to adverse clinical outcomes. Early identification and treatment of anemia may improve cardiovascular morbidity and mortality. No large-scale population data are available specifically for patients with chronic kidney disease regarding prev...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/030079904X2763

    authors: McClellan W,Aronoff SL,Bolton WK,Hood S,Lorber DL,Tang KL,Tse TF,Wasserman B,Leiserowitz M

    更新日期:2004-09-01 00:00:00

  • Cardiovascular risk factor profile in Greece: results from the CARDIO2000 and ATTICA epidemiological studies.

    abstract::During the past decades several epidemiological studies have provided a 'portrait' of the potential candidate for cardiovascular disease, introducing many emerging life-style risk factors such as obesity, unhealthy diet, exposure to passive smoking, lack of exercise, psychosocial stress, and depression, as well as ele...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079902125000525

    authors: Pitsavos CE,Toutouzas PK

    更新日期:2002-01-01 00:00:00